Veterinary Medicines

ANTOX

Authorised
  • Clostridium perfringens, type D, strain 98, toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium novyi, strain 34, Inactivated
  • Clostridium septicum, strain 1098, Inactivated
  • Clostridium perfringens, type B, epsilon toxoid
Download as PDF

Product identification

Medicine name:
АНТОКС
ANTOX
Active substance:
  • Clostridium perfringens, type D, strain 98, toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium novyi, strain 34, Inactivated
  • Clostridium septicum, strain 1098, Inactivated
  • Clostridium perfringens, type B, epsilon toxoid
Target species:
  • Sheep
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Clostridium perfringens, type D, strain 98, toxoid
    4.00
    billion colony forming units
    /
    1.00
    Dose
  • Clostridium perfringens, type C, beta toxoid
    4.00
    billion colony forming units
    /
    1.00
    Dose
  • Clostridium novyi, strain 34, Inactivated
    4.00
    billion colony forming units
    /
    1.00
    Dose
  • Clostridium septicum, strain 1098, Inactivated
    8.00
    billion colony forming units
    /
    1.00
    Dose
  • Clostridium perfringens, type B, epsilon toxoid
    4.00
    billion colony forming units
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Mintech Co EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Mintech Co EOOD
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-2053-25.06.2013
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 7/06/2022
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 7/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."